Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Premium
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • PorteføljeInderes modelportefølje
  • Lær om investering
    • AnalyseskoleLær at læse og forstå aktieanalyse
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • InsidertransaktionerFølg købs- og salgsaktivitet fra virksomhedsinsidere
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Virtuel analytiker-chatStil spørgsmål og få AI-drevne investeringsindsigter med det samme
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Qualisys Q3 Interim Report - A Challenging Quarter, First OnTraq Agreements

QSYSSelskabsmeddelelse12.11.2026, 08.30
Download udgivelse

Qualisys Holding AB hereby publishes the Interim Report for the period July 1 – September 30, 2026. The Report is available as an attached file to this release and on Qualisys website. Below is a summary of the report.

The third quarter marked an important milestone. Our markerless strategy moved from development into commercial reality. OnTraq signed its first agreements with elite clubs in both the Premier League and the NFL, and we pre-launched Prisma Pose for our installed base of biomechanics labs.

As announced in our preliminary results on 20 October, net sales fell short of our expectations, mainly due to delayed orders. EBIT reflects both lower volumes and commercialisation costs in markerless technology. Gross margin improved to 72.2 percent (70.7). Order intake was in line with the same period last year and followed our usual seasonal pattern.

OnTraq's subscription-based model adds recurring revenue that complements our project-based business. We are in final discussions with additional teams in Europe and North America. Together with Prisma Pose and our partnership with Theia, we now meet customer needs from the training ground to the clinic and the research lab.

The fourth quarter is historically our strongest, and our priorities are clear: convert delayed projects into orders, at the same time roll out Prisma Pose across our installed base, sign more OnTraq teams, and strengthen our position in selected engineering application areas. Our financial targets over a business cycle are unchanged.
 
Third Quarter (July-September)

  • Net sales amounted to SEK 46.1 million (54.3), corresponding to a decrease of 15.1 percent (currency-adjusted -16.0 percent).
  • Operating profit (EBIT) amounted to SEK 0.2 million (8.0).
  • Net profit amounted to SEK 1.0 million (6.2).
  • Earnings per share of SEK 0.10 (0.62).
  • Cash flow from operating activities after investments amounted to SEK 5.4 million (-2.1).

First Nine Months of 2026 (January-September)

  • Net sales amounted to SEK 140.5 million (169.0), corresponding to a decrease of 16.9 percent (currency-adjusted -13.4 percent).
  • Operating profit (EBIT) amounted to SEK 0.6 million (17.1).
  • Net profit amounted to SEK 1.5 million (10.1).
  • Earnings per share of SEK 0.15 (1.01).
  • Cash flow from operating activities after investments amounted to SEK 8.1 million (4.7).

For further information, please contact:
Magnus Holm, CFO
E-mail: Magnus.Holm@qualisys.com
Ingemar Pettersson, CEO
E-mail: Ingemar.Pettersson@qualisys.se

About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore, Shanghai and Delhi. Qualisys is certified according to ISO 9001:2015 and ISO 27001:2023. The clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).

Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.

This information is information that Qualisys Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-11-12 08:30 CET.

Attachments
2026 Q3 FINAL